cancer for dose-dependent effect Evaluation of cyclooxygenase-2 inhibition in an orthotopic murine model of lung

[1]  A. Aprikian,et al.  Prostate cancer and use of nonsteroidal anti-inflammatory drugs: systematic review and meta-analysis , 2004, British Journal of Cancer.

[2]  R. Herbst,et al.  Development of an orthotopic model to study the biology and therapy of primary human lung cancer in nude mice. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[3]  V. Starnes,et al.  Cyclooxygenase-2 inhibition decreases primary and metastatic tumor burden in a murine model of orthotopic lung adenocarcinoma. , 2003, The Journal of thoracic and cardiovascular surgery.

[4]  J. Castelao,et al.  Lung cancer and cyclooxygenase-2. , 2003, The Annals of thoracic surgery.

[5]  L. Dwyer-Nield,et al.  Celecoxib reduces pulmonary inflammation but not lung tumorigenesis in mice. , 2002, Carcinogenesis.

[6]  R. Shore,et al.  Aspirin and lung cancer in women , 2002, British Journal of Cancer.

[7]  B. Craig,et al.  Effects of the cyclooxygenase inhibitor, piroxicam, on tumor response, apoptosis, and angiogenesis in a canine model of human invasive urinary bladder cancer. , 2002, Cancer research.

[8]  Li Zhu,et al.  Non-small Cell Lung Cancer Cyclooxygenase-2-dependent Invasion Is Mediated by CD44* , 2001, The Journal of Biological Chemistry.

[9]  J. Masferrer,et al.  COX‐2 is expressed in human pulmonary, colonic, and mammary tumors , 2000, Cancer.

[10]  H. Sheng,et al.  Celecoxib prevents tumor growth in vivo without toxicity to normal gut: lack of correlation between in vitro and in vivo models. , 2000, Cancer research.

[11]  A. Raz,et al.  Indomethacin Inhibits the Accumulation of Tumor Cells in Mouse Lungs and Subsequent Growth of Lung Metastases , 2000, Chemotherapy.

[12]  Y. Kawahito,et al.  Meloxicam inhibits the growth of non-small cell lung cancer. , 2000, Anticancer research.

[13]  T. Hla,et al.  Expression of cyclooxygenase‐2 in prostate carcinoma , 2000, Cancer.

[14]  S. Dey,et al.  Host cyclooxygenase-2 modulates carcinoma growth. , 2000, The Journal of clinical investigation.

[15]  T. Mitsudomi,et al.  Cyclooxygenase-2 inhibitor induces apoptosis and enhances cytotoxicity of various anticancer agents in non-small cell lung cancer cell lines. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[16]  M. Yu,et al.  Non-steroidal anti-inflammatory drugs and bladder cancer prevention , 2000, British Journal of Cancer.

[17]  N. Davies,et al.  Clinical Pharmacokinetics and Pharmacodynamics of Celecoxib , 2000, Clinical pharmacokinetics.

[18]  K. Seibert,et al.  Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors. , 2000, Cancer research.

[19]  A. Castonguay,et al.  Prevention of NNK-induced lung tumorigenesis in A/J mice by acetylsalicylic acid and NS-398. , 1998, Cancer research.

[20]  P. Lipsky,et al.  Cyclooxygenase in biology and disease , 1998, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[21]  A. Castonguay,et al.  Chemopreventive efficacies of aspirin and sulindac against lung tumorigenesis in A/J mice. , 1997, Carcinogenesis.

[22]  R. DuBois,et al.  Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[23]  R. DuBois,et al.  Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2 , 1995, Cell.

[24]  E. Rimm,et al.  Aspirin Use and the Risk for Colorectal Cancer and Adenoma in Male Health Professionals , 1994, Annals of Internal Medicine.

[25]  R. Everson,et al.  Aspirin Use and Lung, Colon, and Breast Cancer Incidence in a Prospective Study , 1994, Epidemiology.

[26]  J. Baron,et al.  Reduced risk of large-bowel adenomas among aspirin users. The Polyp Prevention Study Group. , 1993, Journal of the National Cancer Institute.

[27]  M. Thun,et al.  Aspirin use and risk of fatal cancer. , 1993, Cancer research.

[28]  M. You,et al.  Inhibition of COX-2 and induction of apoptosis: two determinants of nonsteroidal anti-inflammatory drugs' chemopreventive efficacies in mouse lung tumorigenesis. , 2000, Experimental lung research.

[29]  J. Vane,et al.  Cyclooxygenases 1 and 2. , 1998, Annual review of pharmacology and toxicology.

[30]  H. Herschman.  Primary response genes induced by growth factors and tumor promoters. , 1991, Annual review of biochemistry.